{"id":45776,"date":"2021-08-23T10:26:16","date_gmt":"2021-08-23T14:26:16","guid":{"rendered":"http:\/\/pappp.net\/?guid=3d5f792d30bbc3b7bff64db4afc43fa5"},"modified":"2021-08-23T10:26:16","modified_gmt":"2021-08-23T14:26:16","slug":"fda-approves-pfizers-covid-19-vaccine-now-called-comirnaty","status":"publish","type":"post","link":"https:\/\/pappp.net\/?p=45776","title":{"rendered":"FDA approves Pfizer\u2019s COVID-19 vaccine, now called Comirnaty"},"content":{"rendered":"

Source: Ars Technica<\/a><\/p>\n

Article note: Good!\nThat's a dumb fuckin' name, even by drug name standards. \n...and now we watch the people making bad-faith arguments against getting vaccinated move the goalposts again.<\/div>
\n
\"Empty

Enlarge<\/a> \/<\/span> Empty Pfizer-BioNTech COVID-19 vaccine vials (credit: AHMAD GHARABLI<\/a>)<\/p> <\/figure>

<\/a><\/div>\n

The Food and Drug Administration has granted full approval of the Pfizer\/BioNTech COVID-19 vaccine<\/a>, which will now be marketed as Comirnaty (koe-mir’-na-tee), the agency announced Monday.<\/p>\n

The vaccine's full approval—or Biologics License Application (BLA)—applies for use of a two-dose regimen, given three weeks apart, in people ages 16 years and older. It is the first BLA to be issued for a vaccine against COVID-19. The vaccine will still be available under an Emergency Use Authorization (EUA) for adolescents ages 12 to 15 and for use as a third booster dose in certain people with compromised immune systems.<\/p>\n

The name Comirnaty—already in use elsewhere, including Europe—is a mash-up<\/a> of \"COVID-19 immunity\" and \"mRNA\" that is meant to evoke the word \"community.\"<\/p><\/div>

Read 7 remaining paragraphs<\/a> | Comments<\/a><\/p>

\n<\/a> <\/a> <\/a> <\/a>\n<\/div>","protected":false},"excerpt":{"rendered":"

Enlarge \/ Empty Pfizer-BioNTech COVID-19 vaccine vials (credit: AHMAD GHARABLI)
\nThe Food and Dr…<\/p>\n

Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[226],"tags":[],"class_list":["post-45776","post","type-post","status-publish","format-standard","hentry","category-news-2"],"_links":{"self":[{"href":"https:\/\/pappp.net\/index.php?rest_route=\/wp\/v2\/posts\/45776","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pappp.net\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pappp.net\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pappp.net\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/pappp.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=45776"}],"version-history":[{"count":0,"href":"https:\/\/pappp.net\/index.php?rest_route=\/wp\/v2\/posts\/45776\/revisions"}],"wp:attachment":[{"href":"https:\/\/pappp.net\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=45776"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pappp.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=45776"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pappp.net\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=45776"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}